IGF2BP3 and acute myeloid leukemia: To investigate the regulatory relationship between IGF2BP3 and RCC2 and the specific mechanisms of RCC2 in AML, we first detected the correlation between these genes in the GSE37642 and TARGET databases, and the results suggested that RCC2 expression was positively correlated with IGF2BP3 expression (Fig. 6a, b).